2
|
Dumas O, Despreaux T, Perros F, Lau E, Andujar P, Humbert M, Montani D, Descatha A. Respiratory effects of trichloroethylene. Respir Med 2017; 134:47-53. [PMID: 29413507 DOI: 10.1016/j.rmed.2017.11.021] [Citation(s) in RCA: 28] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/05/2017] [Revised: 11/07/2017] [Accepted: 11/28/2017] [Indexed: 12/12/2022]
Abstract
Trichloroethylene (TCE) is a chlorinated solvent that has been used widely around the world in the twentieth century for metal degreasing and dry cleaning. Although TCE displays general toxicity and is classified as a human carcinogen, the association between TCE exposure and respiratory disorders are conflicting. In this review we aimed to systematically evaluate the current evidence for the respiratory effects of TCE exposure and the implications for the practicing clinician. There is limited evidence of an increased risk of lung cancer associated with TCE exposure based on animal and human data. However, the effect of other chlorinated solvents and mixed solvent exposure should be further investigated. Limited data are available to support an association between TCE exposure and respiratory tract disorders such as asthma, chronic bronchitis, or rhinitis. The most consistent data is the association of TCE with autoimmune and vascular diseases such as systemic sclerosis and pulmonary veno-occlusive disease. Although recent data are reassuring regarding the absence of an increased lung cancer risk with TCE exposure, clinicians should be aware of other potential respiratory effects of TCE. In particular, occupational exposure to TCE has been linked to less common conditions such as systemic sclerosis and pulmonary veno-occlusive disease.
Collapse
Affiliation(s)
- Orianne Dumas
- Inserm, U1168, VIMA: Aging and Chronic Diseases, Epidemiological and Public Health Approaches, F-94807, Villejuif, France; Univ Versailles St-Quentin-en-Yvelines, UMR-S 1168, F-78180, Montigny le Bretonneux, France
| | - Thomas Despreaux
- Inserm, U1168, VIMA: Aging and Chronic Diseases, Epidemiological and Public Health Approaches, F-94807, Villejuif, France; Univ Versailles St-Quentin-en-Yvelines, UMR-S 1168, F-78180, Montigny le Bretonneux, France; AP-HP UVSQ, Occupational Health Unit/Population-Based Epidemiological Cohorts Unit, UMS 011, University Hospital of Poincaré, Garches, France
| | - Frédéric Perros
- Univ. Paris-Sud, Faculté de Médecine, Le Kremlin Bicêtre, F-94270, France; AP-HP, Centre de Référence de l'Hypertension Pulmonaire Sévère, Département Hospitalo-Universitaire (DHU) Thorax Innovation (TORINO), Service de Pneumologie, Hôpital de Bicêtre, Le Kremlin Bicêtre, F-94270, France; UMR_S 999, Univ. Paris-Sud, INSERM, Laboratoire D'Excellence (LabEx) en Recherche sur le Médicament et l'Innovation Thérapeutique (LERMIT), Centre Chirurgical Marie Lannelongue, Le Plessis Robinson, F-92350, France
| | - Edmund Lau
- Sydney Medical School, University of Sydney, Camperdown, NSW 2050, Australia
| | - Pascal Andujar
- CHI Créteil, Service de Pneumologie et Pathologie Professionnelle, F-94000, Creteil, France
| | - Marc Humbert
- Univ. Paris-Sud, Faculté de Médecine, Le Kremlin Bicêtre, F-94270, France; AP-HP, Centre de Référence de l'Hypertension Pulmonaire Sévère, Département Hospitalo-Universitaire (DHU) Thorax Innovation (TORINO), Service de Pneumologie, Hôpital de Bicêtre, Le Kremlin Bicêtre, F-94270, France; UMR_S 999, Univ. Paris-Sud, INSERM, Laboratoire D'Excellence (LabEx) en Recherche sur le Médicament et l'Innovation Thérapeutique (LERMIT), Centre Chirurgical Marie Lannelongue, Le Plessis Robinson, F-92350, France
| | - David Montani
- Univ. Paris-Sud, Faculté de Médecine, Le Kremlin Bicêtre, F-94270, France; AP-HP, Centre de Référence de l'Hypertension Pulmonaire Sévère, Département Hospitalo-Universitaire (DHU) Thorax Innovation (TORINO), Service de Pneumologie, Hôpital de Bicêtre, Le Kremlin Bicêtre, F-94270, France; UMR_S 999, Univ. Paris-Sud, INSERM, Laboratoire D'Excellence (LabEx) en Recherche sur le Médicament et l'Innovation Thérapeutique (LERMIT), Centre Chirurgical Marie Lannelongue, Le Plessis Robinson, F-92350, France
| | - Alexis Descatha
- Inserm, U1168, VIMA: Aging and Chronic Diseases, Epidemiological and Public Health Approaches, F-94807, Villejuif, France; Univ Versailles St-Quentin-en-Yvelines, UMR-S 1168, F-78180, Montigny le Bretonneux, France; AP-HP UVSQ, Occupational Health Unit/Population-Based Epidemiological Cohorts Unit, UMS 011, University Hospital of Poincaré, Garches, France.
| |
Collapse
|
3
|
Kulhawik D, Walecki J. Toxic lung injury in a patient addicted to "legal highs" - case study. Pol J Radiol 2015; 80:62-6. [PMID: 25691919 PMCID: PMC4319657 DOI: 10.12659/pjr.892334] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/27/2014] [Accepted: 10/23/2014] [Indexed: 01/15/2023] Open
Abstract
Background Toxic lung injury may manifest itself in many different ways, ranging from respiratory tract irritation and pulmonary edema in severe cases to constrictive bronchiolitis, being a more distant consequence. It is most often the result of accidental exposure to harmful substances at work, at home, or a consequence of industrial disaster. Case Report This article presents a case of toxic lung injury which occurred after inhalation of legal highs, the so-called “artificial hashish” and at first presented itself radiologically as interstitial pneumonia with pleural effusion and clinically as hypoxemic respiratory insufficiency. After treatment with high doses of steroids, it was histopathologically diagnosed as organizing pneumonia with lipid bodies. Conclusions Due to the lack of pathognomonic radiological images for toxic lung injury, information on possible etiology of irritants is very important. As novel psychoactive substances appeared in Europe, they should be considered as the cause of toxic lung injury.
Collapse
Affiliation(s)
- Dorota Kulhawik
- Department of Radiology, Mazovian Center for Treatment of Lung Diseases and Tuberculosis in Otwock, Otwock, Poland
| | - Jerzy Walecki
- Department of Radiology and Diagnostic Imaging, Independent Public Clinical Hospital, Otwock, Poland
| |
Collapse
|
5
|
Gustafsson Å, Svensson-Elfsmark L, Lorentzen JC, Bucht A. Strain differences influence timing and magnitude of both acute and late inflammatory reactions after intratracheal instillation of an alkylating agent in rats. J Appl Toxicol 2013; 34:272-80. [DOI: 10.1002/jat.2878] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/10/2012] [Revised: 02/22/2013] [Accepted: 02/22/2013] [Indexed: 11/05/2022]
Affiliation(s)
- Åsa Gustafsson
- Division of CBRN Defence and Security; Swedish Defence Research Agency; Umeå Sweden
- Department of Public Health and Clinical Medicine; Unit of Respiratory Medicine, Umeå University; Umeå Sweden
| | | | - Johnny C. Lorentzen
- The Institute of Environmental Health; Unit of Work Environment Toxicology, Karolinska Institute; Stockholm Sweden
| | - Anders Bucht
- Division of CBRN Defence and Security; Swedish Defence Research Agency; Umeå Sweden
- Department of Public Health and Clinical Medicine; Unit of Respiratory Medicine, Umeå University; Umeå Sweden
| |
Collapse
|